ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Peptides
Volume 27, Issue 7, July 2006, Pages 1676-1684
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (558 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.peptides.2006.01.018    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2006 Elsevier Inc. All rights reserved.

NMR structure of the viral peptide linked to the genome (VPg) of poliovirus

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Catherine H. Scheina, Corresponding Author Contact Information, E-mail The Corresponding Author, Numan Oezguena, David E. Volka, Ravindranath Garimellaa, Aniko Paulb and Werner Brauna

aSealy Center for Structural Biology and Molecular Biophysics, Department of Human Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0857, USA

bDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11790, USA


Received 10 November 2005; 
revised 24 January 2006; 
accepted 24 January 2006. 
Available online 15 March 2006.

Abstract

VPgs are essential for replication of picornaviruses, which cause diseases such as poliomyelitis, foot and mouth disease, and the common cold. VPg in infected cells is covalently linked to the 5′ end of the viral RNA, or, in a uridylylated form, free in the cytoplasm. We show here the first solution structure for a picornaviral VPg, that of the 22-residue peptide from poliovirus serotype 1. VPg in buffer is inherently flexible, but a single conformer was obtained by adding trimethylamine N-oxide (TMAO). TMAO had only minor effects on the TOCSY spectrum. However, it increased the amount of structured peptide, as indicated by more peaks in the NOESY spectrum and an up to 300% increase in the ratio of normalized NOE cross peak intensities to that in buffer. The data for VPg in TMAO yielded a well defined structure bundle with 0.6 Å RMSD (versus 6.6 Å in buffer alone), with 10–30 unambiguous constraints per residue. The structure consists of a large loop region from residues 1 to 14, from which the reactive tyrosinate projects outward, and a C-terminal helix from residues 18 to 21 that aligns the sidechains of conserved residues on one face. The structure has a stable docking position at an area on the poliovirus polymerase crystal structure identified as a VPg binding site by mutagenesis studies. Further, UTP and ATP dock in a base-specific manner to the reactive face of VPg, held in place by residues conserved in all picornavirus VPgs.

Keywords: Viral replication; Polymerase interaction; Picornavirus; Circular dichroism; Trimethylamine N-oxide (TMAO); Solvent stabilization; Uridylylation; Post-translational modification

Article Outline

1. Introduction
2. Materials and methods
2.1. VPg peptide and solution conditions
2.2. Circular dichroism
2.3. NMR experiments
2.4. Structure calculation with NOAH/DIAMOD
2.5. %NOE intensity
2.6. Molecular docking
3. Results
3.1. CD and NMR spectra of VPg in different solvent environments
3.2. The structure bundle in TMAO is better defined
3.3. TMAO increases the amount of structured peptide
3.4. Docking studies with the stabilized structure
4. Discussion
4.1. Conserved residues interact with the reactive tyrosine in the structure
5. Conclusion
Acknowledgements
Appendix A. Supplementary data
References






Corresponding Author Contact InformationCorresponding author. Tel.: +1 409 747 6843; fax: +1 409 747 6000.

Peptides
Volume 27, Issue 7, July 2006, Pages 1676-1684
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.